Mergers & Acquisitions

The corporate dissolution of the former 23andMe Holding Co. is entering its final stage. A decisive legal milestone was reached...

The biotechnology firm Enzo Biochem has completed its departure from public markets. The company's shares have been delisted following its...

While Flushing Financial has released its full-year results, the investment community's primary focus remains fixed on its pending merger with...

Eli Lilly & Company is currently benefiting from two significant and concurrent developments that bolster its business outlook. These events...

Investors in Uranium Energy Corp. (UEC) are watching two significant catalysts: a pivotal shareholder vote at a partner company and...

Following a series of recent acquisitions, Pedevco has entered a critical operational phase. The market is now closely monitoring the...

A significant leadership transition is underway at Diginex, signaling a strategic consolidation of its recent acquisitions. The company has appointed...

Barrick Gold's strategy to carve out and publicly list its North American assets by late 2026 has encountered a significant...

The publicly traded chapter for CureVac has officially closed. The mRNA specialist's shares have ceased trading on public exchanges after...

The French satellite operator Eutelsat has been compelled to adjust its financial roadmap after a key divestment plan was halted...